D.E. Shaw & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $146M | Buy |
672,990
+1,354
| +0.2% | +$300K | 0.09% | 259 |
|
|
2025
Q4 | $153M | Sell |
671,636
-447,509
| -40% | -$102M | 0.08% | 270 |
|
|
2025
Q3 | $259M | Sell |
1,119,145
-421,708
| -27% | -$85.9M | 0.15% | 141 |
|
|
2025
Q2 | $286M | Buy |
1,540,853
+918,609
| +148% | +$171M | 0.2% | 98 |
|
|
2025
Q1 | $130M | Buy |
622,244
+397,071
| +176% | +$77.2M | 0.12% | 206 |
|
|
2024
Q4 | $40M | Sell |
225,173
-401,734
| -64% | -$73.9M | 0.03% | 666 |
|
|
2024
Q3 | $124M | Sell |
626,907
-291,724
| -32% | -$54.4M | 0.11% | 222 |
|
|
2024
Q2 | $158M | Buy |
918,631
+178,932
| +24% | +$29.6M | 0.15% | 147 |
|
|
2024
Q1 | $135M | Sell |
739,699
-326,055
| -31% | -$56.2M | 0.12% | 192 |
|
|
2023
Q4 | $165M | Sell |
1,065,754
-54,054
| -5% | -$7.88M | 0.14% | 152 |
|
|
2023
Q3 | $167M | Sell |
1,119,808
-543,840
| -33% | -$79.8M | 0.17% | 120 |
|
|
2023
Q2 | $224M | Buy |
1,663,648
+1,532,290
| +1,166% | +$225M | 0.23% | 78 |
|
|
2023
Q1 | $20.9M | Buy |
131,358
+5,112
| +4% | +$782K | 0.02% | 867 |
|
|
2022
Q4 | $20.4M | Buy |
126,246
+11,663
| +10% | +$1.79M | 0.02% | 903 |
|
|
2022
Q3 | $15.4M | Buy |
114,583
+12,772
| +13% | +$1.83M | 0.02% | 1029 |
|
|
2022
Q2 | $15.6M | Sell |
101,811
-174,802
| -63% | -$26.7M | 0.02% | 1054 |
|
|
2022
Q1 | $44.8M | Buy |
276,613
+2,481
| +0.9% | +$360K | 0.04% | 539 |
|
|
2021
Q4 | $37.1M | Buy |
274,132
+33,958
| +14% | +$4.01M | 0.03% | 709 |
|
|
2021
Q3 | $25.9M | Buy |
240,174
+167,678
| +231% | +$19.2M | 0.02% | 863 |
|
|
2021
Q2 | $8.17M | Buy |
72,496
+52,250
| +258% | +$5.88M | 0.01% | 1668 |
|
|
2021
Q1 | $2.19M | Buy |
20,246
+12,672
| +167% | +$1.36M | ﹤0.01% | 2509 |
|
|
2020
Q4 | $812K | Sell |
7,574
-630,923
| -99% | -$60.6M | ﹤0.01% | 3160 |
|
|
2020
Q3 | $55.9M | Sell |
638,497
-833,134
| -57% | -$78.4M | 0.06% | 380 |
|
|
2020
Q2 | $144M | Sell |
1,471,631
-2,314,812
| -61% | -$204M | 0.17% | 109 |
|
|
2020
Q1 | $288M | Sell |
3,786,443
-309,916
| -8% | -$26.4M | 0.45% | 29 |
|
|
2019
Q4 | $363M | Sell |
4,096,359
-1,175,131
| -22% | -$97.6M | 0.41% | 24 |
|
|
2019
Q3 | $399M | Sell |
5,271,490
-1,119,613
| -18% | -$76.8M | 0.49% | 21 |
|
|
2019
Q2 | $465M | Buy |
6,391,103
+296,368
| +5% | +$23.3M | 0.58% | 16 |
|
|
2019
Q1 | $491M | Buy |
6,094,735
+4,979,335
| +446% | +$407M | 0.63% | 10 |
|
|
2018
Q4 | $103M | Sell |
1,115,400
-660,112
| -37% | -$58.1M | 0.14% | 164 |
|
|
2018
Q3 | $168M | Sell |
1,775,512
-336,902
| -16% | -$31.9M | 0.2% | 100 |
|
|
2018
Q2 | $196M | Buy |
2,112,414
+416,639
| +25% | +$40.7M | 0.26% | 74 |
|
|
2018
Q1 | $161M | Buy |
1,695,775
+708,775
| +72% | +$77.9M | 0.22% | 95 |
|
|
2017
Q4 | $95.5M | Sell |
987,000
-128,673
| -12% | -$12.1M | 0.13% | 183 |
|
|
2017
Q3 | $99.1M | Sell |
1,115,673
-1,981,774
| -64% | -$151M | 0.15% | 158 |
|
|
2017
Q2 | $225M | Sell |
3,097,447
-314,837
| -9% | -$21.2M | 0.37% | 39 |
|
|
2017
Q1 | $222M | Buy |
3,412,284
+2,490,505
| +270% | +$157M | 0.39% | 37 |
|
|
2016
Q4 | $57.7M | Sell |
921,779
-1,399,123
| -60% | -$85.4M | 0.1% | 243 |
|
|
2016
Q3 | $146M | Buy |
2,320,902
+370,649
| +19% | +$24M | 0.26% | 70 |
|
|
2016
Q2 | $121M | Sell |
1,950,253
-2,753,749
| -59% | -$168M | 0.22% | 96 |
|
|
2016
Q1 | $269M | Sell |
4,704,002
-1,622,594
| -26% | -$90.4M | 0.48% | 28 |
|
|
2015
Q4 | $375M | Buy |
6,326,596
+2,297,831
| +57% | +$132M | 0.56% | 21 |
|
|
2015
Q3 | $219M | Buy |
4,028,765
+1,876,943
| +87% | +$122M | 0.32% | 53 |
|
|
2015
Q2 | $145M | Sell |
2,151,822
-86,740
| -4% | -$5.66M | 0.22% | 88 |
|
|
2015
Q1 | $131M | Sell |
2,238,562
-1,994,260
| -47% | -$120M | 0.2% | 102 |
|
|
2014
Q4 | $277M | Buy |
4,232,822
+3,374,928
| +393% | +$213M | 0.36% | 40 |
|
|
2014
Q3 | $49.6M | Sell |
857,894
-5,615,802
| -87% | -$312M | 0.06% | 350 |
|
|
2014
Q2 | $365M | Buy |
6,473,696
+613,833
| +10% | +$32.2M | 0.5% | 26 |
|
|
2014
Q1 | $301M | Buy |
5,859,863
+2,262,977
| +63% | +$114M | 0.43% | 30 |
|
|
2013
Q4 | $190M | Buy |
3,596,886
+1,640,712
| +84% | +$80.6M | 0.26% | 61 |
|
|
2013
Q3 | $87.5M | Buy |
1,956,174
+1,165,352
| +147% | +$51.7M | 0.14% | 155 |
|
|
2013
Q2 | $32.7M | Buy |
+790,822
| New | +$34.6M | 0.06% | 346 |
|
Other funds holding ABBV
VCM
VPM
D.E. Shaw & Co's ABBV Position: Q1 2026 in Review
D.E. Shaw & Co increased its AbbVie (ABBV) stake by 0.2% in Q1 2026, buying an estimated $300K and bringing the position to 672,990 shares worth $146M. The position accounts for 0.09% of the portfolio, ranked #259.
D.E. Shaw & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $491M in Q1 2019. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- D.E. Shaw & Co held 672,990 shares of AbbVie worth $146M as of Q1 2026.
- D.E. Shaw & Co bought 1,354 AbbVie shares in Q1 2026, an estimated $300K.
- AbbVie made up 0.09% of D.E. Shaw & Co's portfolio in Q1 2026, its #259 holding.
- D.E. Shaw & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- D.E. Shaw & Co's AbbVie position peaked at $491M in Q1 2019.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.